Jack2894 - How can anyone doubt that biotech is going to suffer? Obamacare is going to struggle to keep costs down and look everywhere for cost savings before having to finally having to ration care. One of those sources will be pharmaceuticals. If the drug companies aren't able to make enough money to pay for all of the failures, the number of new drugs will go down.
Also, as implied in this article, the current administration is not too keen on companies making profits, so there is another reason to expect fewer new drugs coming to market.
I just don't understand how anyone can think that the extra burden of Obamacare, and Obama's disdain for the private sector, will not negatively affect these companies and their products.